NCT02048384View on ClinicalTrials.gov

A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 10, 2014

Primary Completion Date

February 28, 2018

Study Completion Date

September 30, 2019

Conditions
Metastatic Pancreatic Adenocarcinoma
Interventions
DRUG

metformin alone (Arm A)

metformin alone

DRUG

metformin (Arm B)

rapamycin + metformin

DRUG

rapamycin (Arm B)

rapamycin + metformin

Trial Locations (2)

21231

Johns Hopkins SKCCC, Baltimore

85258

Scottsdale Healthcare Hospitals DBA Honor Health, Scottsdale

All Listed Sponsors
collaborator

Stand Up To Cancer

OTHER

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT02048384 - A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer | Biotech Hunter | Biotech Hunter